Gdm Screening in Different Trimesters: What Are the Recommendations?

by

Gestational Diabetes Mellitus (GDM) is a condition that affects many pregnant women worldwide. Proper screening is essential for early detection and management to ensure the health of both mother and baby. The timing and methods of screening vary depending on the trimester of pregnancy.

First Trimester Screening

Screening for GDM during the first trimester is typically recommended for women with risk factors such as obesity, a history of GDM, or a family history of diabetes. The main goal is to identify women with pre-existing diabetes or early GDM.

Common tests include:

  • Fasting blood glucose test
  • Hemoglobin A1c test
  • Oral glucose tolerance test (OGTT), if indicated

Second Trimester Screening

The standard screening for GDM is usually performed between 24 and 28 weeks of gestation. This is when insulin resistance tends to increase due to hormonal changes.

The most common method is the 75-gram oral glucose tolerance test (OGTT). It involves fasting overnight, then drinking a glucose solution, with blood samples taken at fasting, 1 hour, and 2 hours after ingestion.

Based on the results, healthcare providers can diagnose GDM and recommend appropriate management strategies.

Post-Delivery and Follow-up

Screening doesn’t end after delivery. Women diagnosed with GDM should be retested postpartum, typically around 6 to 12 weeks after birth, to check for persistent glucose intolerance or diabetes.

Long-term follow-up is important because women with GDM are at higher risk of developing type 2 diabetes later in life. Lifestyle modifications and regular screening can help manage this risk.

Summary of Recommendations

  • Screen high-risk women early in pregnancy (first trimester).
  • Perform routine GDM screening between 24-28 weeks for all pregnant women.
  • Use the 75-gram OGTT as the standard test during the second trimester.
  • Follow up postpartum to monitor glucose levels.

Adhering to these guidelines helps ensure early detection and management of GDM, promoting healthier pregnancies and long-term health for women.